Penn Medicine Abramson Cancer Center


 

Expert Discussion on Melanoma Management: What Are the Complications from SLNB and the Role of Gene Expression Profiling? Are Biomarkers Important to Determine Neoadjuvant Trials Enrolment?

180 views
March 4, 2021
Comments 0
Login to view comments. Click here to Login